INVO Fertility, Inc.
IVFNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $6.6M | $3.0M | $822,196 | $4.2M | $1.0M | $1.5M |
| Operating income | −$8.1M | −$6.8M | −$10.6M | −$5.2M | −$5.5M | −$1.8M |
| Net income | −$9.1M | −$8.0M | −$10.9M | −$6.7M | −$8.3M | −$2.2M |
| Total assets | $46.4M | $18.5M | $4.1M | $10.5M | $10.9M | $1.8M |
| Total liabilities | $26.2M | $17.6M | $5.1M | $3.2M | $5.2M | $5.5M |
| Equity | $12.7M | $892,825 | −$977,612 | $7.3M | $5.7M | −$3.7M |
| EPS (diluted) | $-30.19 | $-67.37 | $-17.97 | $-0.63 | $-1.52 | $-0.45 |
| Shares out. | 2.7M | 14.0M | 12.1M | 10.4M | 157.8M | 154.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −123.8%
- Net margin
- −138.6%
- Return on equity
- −71.4%
- Return on assets
- −19.6%
- Return on capital (ROCE)
- −28.5%
- Liabilities / assets
- 56.5%
- Debt / equity
- 2.06×
- Book value / share
- $4.65
- Revenue growth (YoY)
- 117.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -7.73distress
- Accruals / assets
- −13.2%clean
- Beneish M-Score
- -2.39normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 18, 2026
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2026
- NT 10-Qmissed a reporting deadline ↗Nov 17, 2025
- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Armistice Capital, LlcPassive (13G)May 15, 2026
- Glenbrook Capital ManagementPassive (13G)Apr 1, 2026
- Five Narrow Lane LpPassive (13G)Jan 21, 2026
- Greenblock Capital, LlcPassive (13G)Oct 28, 2025
- Intracoastal Capital, LlcPassive (13G)May 9, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 123,076 | 2.6 | +17.2% |
| Apr 30, 2026 | 105,026 | 3.3 | +9.8% |
| Apr 15, 2026 | 95,664 | 2.1 | +21.1% |
| Mar 31, 2026 | 79,020 | 1.0 | -76.3% |
| Mar 13, 2026 | 333,878 | 1.3 | -37.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard notice · Regulation FD disclosureApr 29, 2026
- Amended charter or bylaws · Other material eventMar 31, 2026
- Entered a material agreement · Completed an acquisition or disposition · Unregistered equity sale · Amended charter or bylaws · Other material eventFeb 24, 2026
- Entered a material agreement · Unregistered equity sale · Other material eventJan 30, 2026
- Amended charter or bylaws · Shareholder voteJan 26, 2026
- Director / officer change · Other material eventJan 6, 2026
- Entered a material agreement · Other material eventDec 17, 2025
- Entered a material agreement · Unregistered equity sale · Other material eventDec 5, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- NT 10-QMay 18, 2026
- SCHEDULE 13G/AMay 15, 2026
- 8-KApr 29, 2026
- SCHEDULE 13GApr 1, 2026
- NT 10-KApr 1, 2026
- 8-KMar 31, 2026
- 8-KFeb 24, 2026
- SCHEDULE 13GFeb 17, 2026
- 424B3Feb 12, 2026
- EFFECTFeb 10, 2026
- S-8Feb 6, 2026
- CORRESPFeb 6, 2026
- UPLOADFeb 6, 2026
- S-1Feb 2, 2026
- 8-KJan 30, 2026